Novavax CEO Stanley Erck

Novavax Covid-19 Vaccine Shows 89% Efficacy in UK Trials

Novavax Inc has said its coronavirus vaccine is 89.3% effective in preventing Covid-19 in a trial conducted in the United…

4 years ago